Suma Krishnan

President, R&D, Director, 10% owner, Krystal Biotech

Bought, 12 months

$0.0M

Sold, 12 months

$34.3M

Companies

Latest trade

Sep 4, 2026

Companies

Krystal BiotechPresident, R&D, Director, 10% owner −$34.3M

Trades

KRYS Sold 25,000 shares at $359.32 · planned $9.0M Sep 4

KRYS Sold 25,000 shares at $308.12 · planned $7.7M Jun 4

KRYS Sold 25,000 shares at $263.21 · planned $6.6M Mar 4

KRYS Sold 50,000 shares at $220.15 · planned $11.0M Dec 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.